US2014357580A1PendingUtilityA1

Anti-microbial compositions

Assignee: BIOTELLIGA HOLDINGS LTDPriority: Aug 20, 2010Filed: Aug 21, 2014Published: Dec 4, 2014
Est. expiryAug 20, 2030(~4.1 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 31/10A61P 31/04A01N 63/30A01N 43/08A01N 49/00C07H 1/00A61K 31/7048C07D 493/04A01N 43/16A61K 31/7042A01N 43/04A61K 31/366
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Antimicrobial compounds from Epicoccum purpurascens (syn. E. negrum ) for use against plant and fungi pathogens. An orange yellow metabolite was isolated, the structure elucidated as a small group of compounds Epipyrone A-C and fungicidal activity demonstrated against plant pathogens, for example Botrytis cinerea and Lecanicillium muscarium . Agricultrual and pharmaceutical compositions are provide, and use thereof in treating microbial infections in an animal or plant are also provided.

Claims

exact text as granted — not AI-modified
What we claim is: 
     
         1 . An agricultural composition comprising:
 an agriculturally acceptable carrier; and   an anti-microbial compound of formula (I):   
       
         
           
           
               
               
           
         
         wherein 
         R is selected from the group consisting of: 
         C-β-D-galactopyranose; C-α-D-galactofuranose; C-β-D-galactofuranose; C-β-L-galactopyranose; C-α-L-galactofuranose; C-β-L-galactofuranose; or related pyranose; and 
         a salt, derivative, tautomer, stereoisomer, hydrate, solvate or sugar analogue thereof. 
       
     
     
         2 . A pharmaceutical composition comprising:
 a pharmaceutically acceptable carrier or diluent; and   an anti-microbial compound of formula (I):   
       
         
           
           
               
               
           
         
         wherein 
         R is selected from the group consisting of: 
         C-β-D-galactopyranose; C-α-D-galactofuranose; C-β-D-galactofuranose; C-β-L-galactopyranose; C-α-L-galactofuranose; C-β-L-galactofuranose; or related pyranose; and 
         a salt, derivative, tautomer, stereoisomer, hydrate, solvate, sugar analogue, prodrug thereof. 
       
     
     
         3 . The composition as claimed in  claim 1  wherein the composition is in the form of a powder. 
     
     
         4 . The composition as claimed in  claim 2  wherein the composition is in the form of a powder. 
     
     
         5 . An antimicrobial solution, which comprises a composition according to  claim 1 . 
     
     
         6 . Use of a compound of formula (I): 
       
         
           
           
               
               
           
         
         wherein 
         R is selected from the group consisting of: 
         C-β-D-galactopyranose; C-α-D-galactofuranose; C-β-D-galactofuranose; C-β-L-galactopyranose; C-α-L-galactofuranose; C-β-L-galactofuranose; or related pyranose; and 
         a salt, derivative, tautomer, stereoisomer, hydrate, solvate or sugar analogue thereof in the manufacture of a composition for the treatment of a microbial infection in a plant or a plant part thereof. 
       
     
     
         7 . The agricultural composition as claimed in  claim 6  wherein the microbial infection is a fungal infection. 
     
     
         8 . The agricultural composition as claimed in  claim 6  wherein the plant part is a fruit crop plant or a vegetable crop plant. 
     
     
         9 . Use of a compound of formula (I): 
       
         
           
           
               
               
           
         
         wherein 
         R is selected from the group consisting of: 
         C-β-D-galactopyranose; C-α-D-galactofuranose; C-β-D-galactofuranose; C-β-L-galactopyranose; C-α-L-galactofuranose; C-β-L-galactofuranose; or related pyranose; and 
         a salt, derivative, tautomer, stereoisomer, hydrate, solvate, sugar analogue or prodrug thereof in the manufacture of a medicament for the treatment of microbial infection in an animal or a animal part thereof. 
       
     
     
         10 . The use as claimed in  claim 9  wherein the animal is a human. 
     
     
         11 . A method of preventing, removing or inhibiting a microbial infection in a plant or plant part thereof, comprising the step:
 applying to the plant or plant part thereof a treatment effective amount of a composition comprising:   a compound of formula (I):   
       
         
           
           
               
               
           
         
         wherein 
         R is selected from the group consisting of: 
         C-β-D-galactopyranose; C-α-D-galactofuranose; C-β-D-galactofuranose; C-β-L-galactopyranose; C-α-L-galactofuranose; C-β-L-galactofuranose; or related pyranose; and 
         an agriculturally acceptable salt, derivative, tautomer, stereoisomer, hydrate, solvate or sugar analogue thereof. 
       
     
     
         12 . The method as claimed in  claim 11  wherein the method also comprises the step of:
 applying to the plant or plant part thereof a treatment effective amount of the composition to prevent or inhibit the growth of  Botrytis  or  Lecanicillium.    
 
     
     
         13 . The method as claimed in  claim 11  wherein the plant part is a fruit or a vegetable. 
     
     
         14 . A method of preventing, treating or ameliorating a microbial infection, which comprises administering a composition as claimed in  claim 2 , to a subject in need of such prevention, treatment or amelioration. 
     
     
         15 . The method as claimed in  claim 14  wherein the subject is a non-human animal subject. 
     
     
         16 . The method as claimed in  claim 14  wherein the administration comprises topically administering the composition. 
     
     
         17 . An antimicrobial solution, which comprises a composition according to  claim 2 .

Join the waitlist — get patent alerts

Track US2014357580A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.